Popular Articles

Sanofi-Aventis, GlaxoSmithKline Will Donate Influenza Vaccines To WHO
The drugmaker Sanofi-Aventis will donate millions of doses of a vaccine that offers protection against the H1N1 (swine flu) virus to the WHO once the vaccine is ready, the company"s chief executive officer announced Tuesday, Reuters reports (Elsner, Reuters, 6/17). The AP/Google.com writes, "Exceptional times require exceptional responses. We need to act responsibly and we all have to play our part," Sanofi CEO Christopher Viehbacher said in a statement released during the Pacific Health Summit in Seattle. "This flexible donation aims to help the WHO address the needs of these most vulnerable populations," he said.
pharmacy online
MIT And CDC Discover Why H1N1 Flu Spreads Inefficiently - Virus Ill-suited For Rapid Transmission, But Researchers Say New Strain Could Mutate
A team from MIT and the Centers for Disease Control and Prevention has found a genetic explanation for why the new H1N1 "swine flu" virus has spread from person to person less effectively than other flu viruses.
News of the day
Researchers Working On How Gold Nanoparticles Illuminated With Laser Light May Be Able To Detect And Treat Cancer
At a technical breakfast, Romain Quidant presented his research into the detection and treatment of cancer using gold nanoparticles illuminated with laser light. Quidant, who was recently awarded the Fresnel Prize 2009 that recognizes the highest level of excellence amongst emerging researchers in the field of photonics, is an ICREA researcher at the UPC"s Institute of Photonic Sciences (ICFO) and a fellow of the Cellex Foundation Barcelona.
Public Health

Breast Cancer On The Latest Cancer Waiting Times Stats, Released Today

Dr Alexis Willett, Head of Policy & Involvement at Breakthrough Breast Cancer, says: "Women tell us that waiting for a diagnosis is extremely distressing regardless of the outcome. Breakthrough is pleased that almost all breast units are seeing patients who are "urgently" referred within two weeks, however, by the end of 2009, both urgent and routine referrals should be seen by a specialist within this timescale. We would also like to know how long patients are currently waiting for "routine" referrals and be reassured that this deadline will be met." Breakthrough Breast Cancer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):